Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
Calendar
prev February 2023
Mon Tue Wed Thu Fri Sat Sun
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28
Building on the success of Rosa Khutor resort, the $1 bln project will bring quality hotels and rehabilitation facilities, new skiing tracks for over a million of visitors per year while creating thousands of new jobs More Topics Interros / VEB.RF / Vasta Discovery / Sochi
18.06.2021
Interros has not applied for the buyback of its Norilsk Nickel shares. As a result of the buyback, Interros share in Norilsk Nickel will increase, which is in line with our long-term strategy.
More Topics Interros / Norilsk Nickel / buyback
22.07.2020
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
More Topics Petrovax Pharm
02.06.2020
The Three Volcanoes Park LLC  will build a world-class tourism cluster in the area of Vilyuchinsky, Mutnovsky and Gorely volcanoes, with access to Vilyuchinsky Bay.
More Topics "Three Volcanoes" Park
17.04.2020
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More Topics Petrovax Pharm